KemPharm, Inc.: Revision history

20 August 2022

• curprev 05:3105:31, 20 August 2022 95.149.241.133 talk 1,460 bytes +11 No edit summary undo

13 August 2022

• curprev 06:4406:44, 13 August 2022 109.180.50.163 talk 1,449 bytes +15 No edit summary undo

29 July 2022

• curprev 22:1322:13, 29 July 2022 >Chris 1,434 bytes +1,434 Created page with "KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas..."